Table 3. Nature and results of altered biological treatment course during COVID-19-related restriction period (n=277).
n | % | Mean±SD | |
Continued medications | |||
Continued as it was before | 178 | 64.3 | |
Stopped only biological and synthetic therapy | 22 | 7.9 | |
Decreased or skipped the dose of biological therapy | 38 | 13.7 | |
Stopped all of the medications | 39 | 14.1 | |
Disease activity* (Visual Analog Scale) | 4.4±2.8 | ||
Complaints after treatment changes Worsened | 91 | 32.9 | |
Decreased | 3 | 1.1 | |
Unchanged | 183 | 66.1 | |
SD: Standard deviation; * Disease activity was evaluated with a global health assessment using Visual Analog Scale, since physical examination of the cases and laboratory measurements could not be performed. |